Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 TPIP versus placebo in progressive pulmonary fibrosis
MOH_2026-10-15_017094Phase 3Not yet recruiting
- Sponsor
- Insmed Incorporated
- Start
- Oct 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary fibrosis (PF) comparing TPIP with Matching placebo (2 arms). Primary endpoint: Primary endpoint not reported. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
treprostinil palmitil
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on MOH_2026-10-15_017094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2026-10-15_017094.